Dr. Mark N. Hendrixson, MD
Oncologist | Medical Oncology
29 E Stanley St Crossville TN, 38555About
Dr. Mark Hendrixson is an oncologist practicing in Crossville, TN. Dr. Hendrixson specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Hendrixson manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University of Tennessee Memphis - College of Medicine medical degree 0
Board Certification
American Board of Internal Medicine (ABIM)
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Faculty Titles & Positions
- Vice Chief of Staff Jamestown Regional Medical Center -
- Medical Director Quality Hospice Care -
Awards
- Patients’ Choice Award 2016
- On-Time Doctor Award 2016
Treatments
- Anemia
- Lung Cancer
- Extra Corporeal Shockwave Therapy
Professional Memberships
- American Society of Clinical Oncology
- American College of Physicians
- Tennessee Oncology Practice Society
Fellowships
- East Tennessee State University medical oncology
Dr. Mark N. Hendrixson, MD's Practice location
Dr. Mark N. Hendrixson, MD's reviews
Write ReviewMedia Releases
Get to know Medical Oncologist Dr. Mark N. Hendrixoson, who serves patients in Crossville, Tennessee.
A board-certified medical oncologist, Dr. Hendrixson sees patients at his private practice, Upper Cumberland Cancer Care. He has special training in symptomatic care and end of life issues. He also has an interest in integrative oncology. This is the use of natural and complementary therapies for the relief of symptoms of cancer or its treatment.
Upper Cumberland Cancer Care is the premier oncology practice in Crossville, Tennessee and the surrounding area and is dedicated to providing patients with the knowledge, hope and support that will empower them to take an active role in their treatment and healing options. They are committed to providing patients with exceptional service, care and education.
Before embarking on his professional journey, Dr. Hendrixson received his medical degree from the University of Tennessee Memphis – College of Medicine and completed his residency in internal medicine at East Tennessee State University in Johnson City, TN. He then completed his fellowship in medical oncology at East Tennessee State University, as well.
As a testament of his continued education, he is board-certified in medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.
Alongside his private practice, Dr. Hendrixson served as the Vice Chief of Staff at Jamestown Regional Medical Center. He also served as Medical Director for Quality Hospice Care, based in Jamestown, Tennessee for over two years.
In good standing with a number of professional organizations, he is an active member of the American Society of Clinical Oncology, the American College of Physicians, and the Tennessee Oncology Practice Society.
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. They treat cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy.
Among his various accolades, Dr. Hendrixson has been the recipient of the Patients’ Choice Award (2016) and On-Time Doctor Award (2016).
A Crossville native with family roots going back several generations, he and his wife, Jan, live in the northern part of the county on property that has been in his family for over 100 years. They are involved in companion animal rescue, and are principals in a 501©3 public charity – Focus on Cumberland County Animal Safety (FOCCAS).
Recommended Articles
- How Retaining One Normal BRCA Gene Influences Survival in Ovarian Cancer Patients
The National Cancer Institute reports that around 250,000 people will be diagnosed with breast cancer this year, and about 22,000 with ovarian cancer. While the survival rate among patients with breast cancer is significantly higher compared to ovarian cancer – the NCI reports about 40,000 of the...
- How to Prepare for Chemotherapy
How to prepare for chemotherapyFor people who are scheduled to undergo chemotherapy, there are a number of things that should be done to prepare for the procedure. Preparing for chemotherapy can benefit you for both during the procedure and after the procedure. As a result, preparation steps vary in...
- Treatments for Lung Cancer
The nature of cancer, its stage, your overall health, and the condition of your lungs will largely determine the kind of treatment that safeguards your health. If you happen to be an active smoker, quitting the habit would be a precondition for quicker recovery from cancer. Lung cancer is one the...
- Cancers that Cause Blood in the Urine (Hematuria)
The presence of blood in the urine may be accompanied by pain during urination or it could also be painless. A painless hematuria may be caused by various health conditions such as cancers.Blood in the UrineThe presence of blood in the urine, may it be microscopic or gross, means something is wrong...
- Colon Cancer
What is colon cancer?Colon cancer is cancer of the large intestine, also known as the colon. If the last segment of the colon, the rectum, has a cancerous growth, it is known as rectal carcinoma. These two conditions are collectively referred to as colorectal cancer.Carcinoma of the colon is the...
- False-Positive Mammograms May Predict the Risk for Breast Cancer
According to a new study published in the Journal of the National Cancer Institute, about 50% of women who get annual mammograms may have at least one false positive reading, and these women may have a higher risk of developing breast cancer. In this study, conducted by Danish researchers, women...